莱美药业
(300006)
| 流通市值：67.47亿 | | | 总市值：67.47亿 |
| 流通股本：10.56亿 | | | 总股本：10.56亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 919,679,977.75 | 926,064,918.34 | 1,045,570,486.36 | 979,958,406.36 |
| 应收票据及应收账款 | 249,907,912.99 | 245,786,026.74 | 255,786,649.32 | 256,868,835.89 |
| 其中：应收票据 | 15,501,777.06 | 17,482,813.51 | 1,105,255.76 | 1,514,084.32 |
| 应收账款 | 234,406,135.93 | 228,303,213.23 | 254,681,393.56 | 255,354,751.57 |
| 应收款项融资 | 4,987,752.66 | 7,136,903.59 | 11,594,114.18 | 12,590,437.14 |
| 预付款项 | 35,107,483.33 | 24,575,919.14 | 33,994,809.98 | 32,286,967.28 |
| 其他应收款合计 | 200,841,869.29 | 149,154,333.55 | 147,187,133.28 | 136,331,121.68 |
| 存货 | 151,447,034.04 | 161,328,811.29 | 171,974,847.79 | 177,671,971.76 |
| 其他流动资产 | 7,973,850 | 7,293,018.75 | 5,117,844.4 | 6,742,798.42 |
| 流动资产合计 | 1,569,945,880.06 | 1,521,339,931.4 | 1,671,225,885.31 | 1,602,450,538.53 |
| 非流动资产: | | | | |
| 长期股权投资 | 251,191,170.32 | 263,825,836.67 | 244,003,308.95 | 235,424,680.32 |
| 其他权益工具投资 | 120,296,486.55 | 120,296,486.55 | 140,728,359.96 | 140,728,359.96 |
| 投资性房地产 | 2,944,340.67 | 3,036,983.9 | 3,122,710.45 | 3,214,883.81 |
| 固定资产 | 240,556,703.85 | 245,854,780.54 | 243,686,634.36 | 247,189,273.14 |
| 在建工程 | 660,498.2 | 614,122.79 | 5,318,428.35 | 7,116,771.79 |
| 使用权资产 | 4,764,366.34 | 5,707,682.26 | 7,125,477.63 | 8,446,410.99 |
| 无形资产 | 129,168,461.11 | 131,181,282.51 | 188,791,786.51 | 184,900,941.8 |
| 开发支出 | 60,776,761.58 | 51,124,797.91 | 41,268,731.59 | 45,380,486.11 |
| 商誉 | 44,945,322.9 | 44,945,322.9 | 44,945,322.9 | 44,945,322.9 |
| 长期待摊费用 | 4,377,299.72 | 4,396,817.4 | 4,301,435.09 | 4,697,089.6 |
| 递延所得税资产 | 156,986,842.1 | 152,393,938.77 | 134,377,377.91 | 131,106,534.22 |
| 其他非流动资产 | 25,836,748.32 | 29,998,725.8 | 33,420,767.21 | 29,646,099.3 |
| 非流动资产合计 | 1,042,505,001.66 | 1,053,376,778 | 1,091,090,340.91 | 1,082,796,853.94 |
| 资产总计 | 2,612,450,881.72 | 2,574,716,709.4 | 2,762,316,226.22 | 2,685,247,392.47 |
| 流动负债: | | | | |
| 短期借款 | 213,671,610.88 | 179,423,110.87 | 297,456,976.66 | 210,957,025 |
| 应付票据及应付账款 | 92,997,281.79 | 93,481,573.89 | 81,058,551.46 | 67,546,759.4 |
| 其中：应付票据 | 3,782,933.11 | - | - | - |
| 应付账款 | 89,214,348.68 | 93,481,573.89 | 81,058,551.46 | 67,546,759.4 |
| 合同负债 | 15,639,011.17 | 13,209,023.14 | 13,217,960.46 | 17,283,582.3 |
| 应付职工薪酬 | 24,708,794.38 | 37,800,831.66 | 23,245,138.5 | 17,484,609.7 |
| 应交税费 | 9,766,028.07 | 7,353,998.96 | 9,298,967.37 | 5,984,604.9 |
| 其他应付款合计 | 283,644,742.25 | 254,761,798.83 | 253,474,385.76 | 262,993,453.62 |
| 应付股利 | 14,700,000 | 14,700,000 | - | - |
| 一年内到期的非流动负债 | 134,204,681.73 | 135,400,883.86 | 139,124,874.81 | 120,104,201.02 |
| 其他流动负债 | 5,961,586.41 | 7,057,646.55 | 1,570,481.43 | 2,091,488.08 |
| 流动负债合计 | 780,593,736.68 | 728,488,867.76 | 818,447,336.45 | 704,445,724.02 |
| 非流动负债: | | | | |
| 长期借款 | 47,518,750 | 57,200,000 | 65,700,000 | 85,050,000 |
| 租赁负债 | 1,086,457 | 1,459,799.24 | 2,299,924.8 | 3,112,738.72 |
| 递延收益 | 4,764,503.01 | 4,447,688.53 | 4,830,161.26 | 5,636,263.44 |
| 递延所得税负债 | 18,887,769.12 | 19,052,883.81 | 19,041,068.49 | 19,180,735.94 |
| 非流动负债合计 | 72,257,479.13 | 82,160,371.58 | 91,871,154.55 | 112,979,738.1 |
| 负债合计 | 852,851,215.81 | 810,649,239.34 | 910,318,491 | 817,425,462.12 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,055,911,205 | 1,055,911,205 | 1,055,911,205 | 1,055,911,205 |
| 资本公积 | 1,506,875,795.4 | 1,506,875,795.4 | 1,484,545,509.32 | 1,484,545,509.33 |
| 其他综合收益 | -56,228,310.98 | -56,228,310.98 | -162,525,734.57 | -162,525,734.57 |
| 盈余公积 | 54,026,897.56 | 54,026,897.56 | 54,026,897.56 | 54,026,897.56 |
| 未分配利润 | -819,708,941 | -804,696,257.4 | -593,278,317.62 | -578,738,419.13 |
| 归属于母公司股东权益合计 | 1,740,876,645.98 | 1,755,889,329.58 | 1,838,679,559.69 | 1,853,219,458.19 |
| 少数股东权益 | 18,723,019.93 | 8,178,140.48 | 13,318,175.53 | 14,602,472.16 |
| 股东权益合计 | 1,759,599,665.91 | 1,764,067,470.06 | 1,851,997,735.22 | 1,867,821,930.35 |
| 负债和股东权益合计 | 2,612,450,881.72 | 2,574,716,709.4 | 2,762,316,226.22 | 2,685,247,392.47 |
| 公告日期 | 2026-04-23 | 2026-03-19 | 2025-10-22 | 2025-08-22 |
| 审计意见(境内) | | 标准无保留意见 | | |